Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

69.18 -0.98 (-1.40%)
Streaming Delayed Price Updated: 12:41 PM EST, Feb 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,448,506
Open 70.18
Bid (Size) 69.17 (200)
Ask (Size) 69.19 (200)
Prev. Close 70.16
Today's Range 68.31 - 70.34
52wk Range 54.11 - 93.25
Shares Outstanding 390,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
1 High-Flying Stock with Impressive Fundamentals and 2 We Ignore
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory

Performance

YTD
+4.0%
+4.0%
1 Month
-2.5%
-2.5%
3 Month
+26.1%
+26.1%
6 Month
-11.1%
-11.1%
1 Year
-21.6%
-21.6%

More News

Read More
News headline image
Stelo Adds Enhanced Smart Meal Logging Features as Dexcom Continues to Transform Personal Glucose Management
From Dexcom, Inc.
Via Business Wire
DexCom Inc. (NASDAQ:DXCM) Combines Strong Fundamentals with Bullish Chart Pattern ↗
Via Chartmill
News headline image
3 Profitable Stocks for Long-Term Investors
Via StockStory
News headline image
Dexcom Schedules Fourth Quarter and Fiscal Year 2025 Earnings Release and Conference Call for February 12, 2026 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
News headline image
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
Abbott Laboratories Shares Plunge 10% Following Q4 Revenue Miss and Diagnostics Weakness
Via MarketMinute
Topics Economy
News headline image
Abbott Shares Slump as Revenue Miss and Exact Sciences Acquisition Jitters Overshadow Earnings Beat
Via MarketMinute
Topics Earnings Economy
News headline image
1 Growth Stock Down 19% to Buy Right Now ↗
Via The Motley Fool
Topics Product Recall
News headline image
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights
From Halper Sadeh LLC
Via Business Wire
Top S&P500 movers in Monday's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook
From DexCom, Inc.
Via Business Wire
News headline image
DexCom (DXCM) Stock Trades Down, Here Is Why
Via StockStory
Topics Artificial Intelligence
News headline image
Dexcom Enters Next Era of Continued Innovation With Jake Leach as President and Chief Executive Officer
From DexCom, Inc.
Via Business Wire
News headline image
3 Nasdaq 100 Stocks Worth Your Attention
Via StockStory
News headline image
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
Via PredictStreet
Topics Economy Lawsuit World Trade
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Find Risky
Via StockStory
Topics Stocks
News headline image
2 Growth Stocks to Buy For 2026 and Beyond ↗
Via The Motley Fool
Topics Economy
News headline image
DexCom Inc (NASDAQ:DXCM) Embodies the Growth at a Reasonable Price (GARP) Strategy ↗
Via Chartmill
News headline image
DEXCOM CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds DXCM Investors of the December 26th Deadline for Contacting the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
The $65 Billion Pulse: How Wearable AI and Telemedicine are Redefining the Future of Healthcare
Via MarketMinute
Topics Artificial Intelligence
News headline image
1 Cash-Heavy Stock for Long-Term Investors and 2 We Avoid
Via StockStory

Frequently Asked Questions

Is DexCom, Inc. - Common Stock publicly traded?
Yes, DexCom, Inc. - Common Stock is publicly traded.
What exchange does DexCom, Inc. - Common Stock trade on?
DexCom, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for DexCom, Inc. - Common Stock?
The ticker symbol for DexCom, Inc. - Common Stock is DXCM on the Nasdaq Stock Market
What is the current price of DexCom, Inc. - Common Stock?
The current price of DexCom, Inc. - Common Stock is 69.18
When was DexCom, Inc. - Common Stock last traded?
The last trade of DexCom, Inc. - Common Stock was at 02/10/26 12:41 PM ET
What is the market capitalization of DexCom, Inc. - Common Stock?
The market capitalization of DexCom, Inc. - Common Stock is 26.98B
How many shares of DexCom, Inc. - Common Stock are outstanding?
DexCom, Inc. - Common Stock has 27B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.